In addition, our data are consistent with recent reports46, 47, 48 showing that ZEB1 or NOTCH1 promotes EMT and EGFR inhibitor resistance in lung cancer cell lines, including HCC4006, PC9 and H1650. Here, NOTCH1 is linked to lung carcinoma.